期刊文献+

成年血液透析患者矿物质及骨代谢紊乱调查 被引量:7

Survey of CKD-MBD in adult patients with hemodialysis
下载PDF
导出
摘要 目的 调查江苏省昆山市第一人民医院维持性血液透析(maintenance hemodialysis,MHD)患者的慢性肾脏病矿物质及骨代谢异常(chronic kidney disease-mineral and bone disorders,CKD-MBD)情况,比较分析老年和非老年患者CKD-MBD的特点,为临床治疗提供依据.方法 调查234例MHD患者的透析龄、透前肌酐、血小板、白蛋白、血色素、血钙、血磷、ALP及iPTH的水平及临床资料,与指南比较分析老年组和非老年组血钙、血磷、ALP及iPTH的特点.结果 我院MHD患者非老年组患病率高于老年组(P<0.05);透析龄、干体重、透前肌酐、白蛋白水平等指标两组间差异无统计学意义(P>0.05);血清钙、磷、iPTH达标率分别为83.76%、19.66%、40.17%.两组比较,老年组血清钙、磷、iPTH、ALP均不同程度的低于非老年组,差异有统计学意义(P<0.05).结论 老年组MHD患者CKD-MBD指标低于非老年组,提示两组患者CKD-MBD发生机制存在差异,老年患者容易合并低转运骨病(akinesis bone disease,ABD). Objective To analyze the prevalence of disorders of calcium and phosphorus metabolism and iPTH in elderly (≥ 65 years old) and non-elderly (< 65 year old) maintenance hemodialysis (MHD) patients.Methods We invstigated 234 MHD patients treated in the hemodialysis centre and analyzed years for dialysis,dry weight,Scr before hemodialysis,platelet (PLT),albumin (Alb),hemoglobin (Hb)、serum Ca,serum phosphate,intact parathyroid hormone (iPTH),and alkaline phosphatase (ALP) in elderly and non-elderly MHD patients.We also compared these data with the guidelines and observed the differencs between the two groups.Results The prevalance rate of CKD in nonelderly patients is higher than that in elderly patients (P<0.05).There is no significant difference in years for dialysis,dry weight,Scr before hemodialysis,PLT and Alb between the two groups (P>0.05).The overall proficiency of serum calcium,serum phosphorus and iPTH was 83.76%,19.66%,40.17%,respectively.Moreover,the proficiency of calcium,phosphorus and iPTH in the elderly MHD patients were significantly lower than those in non-elderly patients (P < 0.05).Conclusion The disorder of serum phosphorus metabolism in the elderly MHD patients is significantly different from that in non-elderly patients,which indicates that the distinct pathogenesis of CKD-MBD in elderly MHD patients.The elderly patients may be suffered from ABD more easily.
出处 《老年医学与保健》 CAS 2014年第5期311-312,336,共3页 Geriatrics & Health Care
关键词 血液透析 慢性肾脏病 钙磷代谢 全段甲状旁腺激素 Maintenance hemodialysis Chronic kidney disease Disorders of calcium and phosphorus metabolism Intact parathyroid hormone
  • 相关文献

参考文献8

  • 1Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in Claim: a cross-sectional survey [J]. Lancet, 2012, 379 (9818): 815-822.
  • 2Canaud B, Tong L, Tentori F, et al. Clinical practices and outcomes in elderly hemodialysis patients: results from the Di- alysis Outcomes and Practice Patterns Study (DOPPS) [J]. Clin J Am Soc Nephrol, 2011, 6 (7): 1651-1662.
  • 3Parilda NI, Hwang SJ, Larson MG, et al. Chronic kidney disease as a predictor of cardiovascular disease (from the Fra- mingham Heart Study) [J]. Am J Cardiol, 2008, 102 (1): 47-53.
  • 4Hu MC, Kuro-o M, Moe OW. Klotho and kidney disease [J]. JNephrol, 2010, 23Suppl16: S136-S144.
  • 5Kiss I, Kiss Z, Ambrus C, etM. Age-dependentparathormone levels and different CKD-MBD treatment practices of dialysis patients in Hungary--results from a nationwide clinical audit [J]. BMCNeplarol, 2013, 14: 155.
  • 6Kansal S, Fried L. Bone disease in elderly individuals with CKD [J]. Adv Chronic Kidney Dis, 2010, 17 (4): e41-e51.
  • 7倪兆慧,周文彦.透析患者无力性骨病的新认识[J].中国血液净化,2009,8(10):523-525. 被引量:22
  • 8李静,李荣山.2010—2011年山西省新进入血液透析患者的流行病学调查[J].中华肾脏病杂志,2013,29(1):6-10. 被引量:35

二级参考文献35

  • 1王质刚.血液净化时机的选择[J].实用医院临床杂志,2005,2(1):5-7. 被引量:24
  • 2王海涛,吴华,毛永辉.低甲状旁腺激素水平的血液透析患者应用1.25mmol/L钙浓度透析液的临床观察[J].中国血液净化,2006,5(7):355-357. 被引量:4
  • 3刘莉,杨莉,王梅.非糖尿病性终末期肾病患者透析时机的变化——2001年和2006年的比较[J].中国血液净化,2007,6(5):242-245. 被引量:15
  • 4Sherrard OJ, Hercz G, Pei Y, et al. The spectrum of bone disease in endstage renal failure: an evolving disorder [J]. Kidney Int, 1993,43: 436-442.
  • 5Malluche H, Monier-Faugere MC. Risk of adynamic bone disease in dialyzed patients[J]. Kidney Int Suppl, 1992, 38:S62-S67.
  • 6Picton ML, Moore PR, Mawer EB, et al. Down-regulation of human osteoblast PTH/PTHrP receptor mRNA in end-stage renal failure[J]. Kidney Int, 2000,58:1440- 1449.
  • 7D'Amour, P. Circulating PTH molecular forms: What we know and what we don' t[J]. Kidney Int Suppl, 2006,S29-S33.
  • 8Panda DE, Miao D, Bolicar I, et al. Inactivation of the 25-hydroxyvitamin Dlalpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis [J]. J Biol Chem, 2004, 279: 16754-16766.
  • 9Van Driel M, KoedumM, Buurman CJ, et al. Evidence that both lalpha, 25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization [J]. J Cell Biochem, 2006,99:922 935.
  • 10Dusso AS, Brown AJ. Mechanism of vitamin D action and its regulation[J]. Am J Kidney Dis, 1998, 32(Suppl 2): S13- S24.

共引文献55

同被引文献53

引证文献7

二级引证文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部